[SRNE] QoQ Quarter Result on 31-Mar-2015 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
05-May-2015
Financial Year
2015
Quarter
31-Mar-2015 [#Q1]
Profit Trend
QoQ- -22.73%
YoY- -3.42%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 1,337 1,103 1,173 977 798 1,276 775 43.69%
PBT -25,413 33,244 -10,975 -10,616 -10,207 -7,605 -8,454 107.86%
Tax 1,186 35,323 -17 -178 1 2 5 3693.87%
NP -23,476 -939 -10,958 -10,438 -8,505 -7,605 -8,454 97.19%
Tax Rate - -106.25% - - - - - -
Total Cost 24,813 2,042 12,131 11,415 9,303 8,881 9,229 93.00%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin -1,755.87 -85.13 -934.19 -1,068.37 -1,065.79 -596.00 -1,090.84 37.22%
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
EPS -0.62 -0.03 -0.30 -0.29 -0.23 -0.27 -0.33 52.08%
EPS Diluted -0.62 -0.03 -0.30 -0.29 -0.23 -0.27 -0.33 52.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.